Related Experiment Video
Updated: Jun 8, 2025

10:39
Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo
Published on: March 8, 2018
8.3K
Glucose variability and diabetic microvascular complications
Casopis Lekaru Ceskych
|November 8, 2024
Summary
Glucose variability, or fluctuations in blood sugar, may independently contribute to microvascular complications in diabetes. Further research is needed to understand its role in diabetic retinopathy, nephropathy, and neuropathy.
Area of Science:
- Endocrinology and Metabolism
- Cardiovascular Research
- Diabetology
Background:
- Inadequate long-term diabetes control, measured by glycated haemoglobin (HbA1c), is linked to microvascular complications.
- Glucose fluctuations are associated with oxidative stress, endothelial dysfunction, and inflammation, contributing to vascular damage.
- The role of glucose variability in microvascular disease remains debated, unlike its established link to macrovascular disease.
Purpose of the Study:
- To review existing research on glucose variability and its association with microvascular complications in diabetes.
- To address the question of whether short-term glucose variability is an independent risk factor for these complications.
- To highlight the need for further investigation into glucose variability parameters.
Main Methods:
- Literature review of studies examining glucose variability.
- Analysis of research connecting glucose variability to diabetic retinopathy, nephropathy, and neuropathy.
- Synthesis of current data on the impact of glucose fluctuations on microvascular health.
Main Results:
- Current data suggest a potential link between glucose variability and microvascular complications.
- The independent contribution of short-term glucose variability requires further investigation.
- Understanding variability parameters is crucial for risk assessment and treatment optimization.
Conclusions:
- Further research is essential to elucidate the precise role of both short-term and long-term glucose variability in diabetic microvascular complications.
- Glucose variability parameters may prove valuable in tailoring treatment strategies and predicting the risk of chronic diabetic complications.
- The findings underscore the importance of considering glucose fluctuations beyond average HbA1c levels for comprehensive diabetes management.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes: Symptoms, Diagnosis, and Complications
508
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
508
Pathophysiology of Diabetes
872
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
872
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Variability: Analysis
126
Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
The range is a simple measure of variability, indicating the difference between the highest and...
126
Hypoglycemia and Glucagon
152
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
152

